These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 16553517

  • 21. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
    Erlandson KM, Sun J, Iwen PC, Rupp ME.
    Clin Infect Dis; 2008 Jan 01; 46(1):30-6. PubMed ID: 18171210
    [Abstract] [Full Text] [Related]

  • 22. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.
    Fiscella RG, Lai WW, Buerk B, Khan M, Rodvold KA, Pulido JS, Labib S, Shapiro MJ, Blair NP.
    Ophthalmology; 2004 Jun 01; 111(6):1191-5. PubMed ID: 15177970
    [Abstract] [Full Text] [Related]

  • 23. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
    Scheetz MH, Qi C, Noskin GA, Warren JR, Postelnick MJ, Malczynski M, Huang J, Zembower TR.
    Diagn Microbiol Infect Dis; 2006 Dec 01; 56(4):407-13. PubMed ID: 16930924
    [Abstract] [Full Text] [Related]

  • 24. Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis.
    Boak LM, Li J, Spelman D, du Cros P, Nation RL, Rayner CR.
    Ann Pharmacother; 2006 Dec 01; 40(7-8):1451-5. PubMed ID: 16772405
    [Abstract] [Full Text] [Related]

  • 25. Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial.
    El-Khoury J, Fishman JA.
    Transpl Infect Dis; 2003 Sep 01; 5(3):121-5. PubMed ID: 14617299
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.
    Anastasiou DM, Thorne GM, Luperchio SA, Alder JD.
    Int J Antimicrob Agents; 2006 Nov 01; 28(5):385-8. PubMed ID: 17046205
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
    Nam HS, Koh WJ, Kwon OJ, Cho SN, Shim TS.
    Int J Antimicrob Agents; 2009 Jan 01; 33(1):92-3. PubMed ID: 18789655
    [No Abstract] [Full Text] [Related]

  • 33. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J, Kresken M, Menke A, Orland A, Weiher H, Morrissey I.
    Int J Antimicrob Agents; 2007 Mar 01; 29(3):322-5. PubMed ID: 17204403
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis.
    Souli M, Sakka V, Galani I, Antoniadou A, Galani L, Siafakas N, Zerva L, Fytrou H, Tsiodras S, Giamarellou H.
    Int J Antimicrob Agents; 2009 Feb 01; 33(2):137-42. PubMed ID: 19013056
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspective.
    McKinnon PS, Carter CT, Girase PG, Liu LZ, Carmeli Y.
    Manag Care Interface; 2007 Jan 01; 20(1):23-34. PubMed ID: 17310650
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.